A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

NCT06834932 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

432

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidaemia

Interventions

DRUG: Placebo
DRUG: Rosuvastatin Dose 1
DRUG: Rosuvastatin dose 2
DRUG: AZD0780

Sponsor

AstraZeneca